Search research articles
Contact Us
Filters
Showing results (61-70 of 97) with videos related to
Page
of 10
Sort By:
ERJ Open Research
|
April 3, 2023
Delivery of noninvasive ventilation to people living with motor neuron disease in the UK
Lucy S Musson, Susan K Baxter, Paul Norman, et al.
Leukemia & Lymphoma
|
April 7, 2010
Large granular lymphocyte leukemia: natural history and response to treatment
Anne F Fortune, Kevin Kelly, Jeremy Sargent, et al.
Cytometry. Part B, Clinical Cytometry
|
September 22, 2018
Inter-laboratory validation of a harmonized PNH flow cytometry assay
Daniel Payne, Ulrika Johansson, David Bloxham, et al.
European Child & Adolescent Psychiatry
|
June 5, 2021
Prioritizing core components of successful transitions from child to adult mental health care: a national Delphi survey with youth, caregivers, and health professionals
Kristin Cleverley, Emma McCann, David O'Brien, et al.
Irish Journal of Medical Science
|
October 17, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias
Helen Fogarty, Anita Dowling, David O'Brien, et al.
BMJ Open
|
February 8, 2017
Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial
Joanna L Henderson, Amy Cheung, Kristin Cleverley, et al.
Brain : a Journal of Neurology
|
June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis
David O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Nature Communications
|
April 11, 2020
TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor trafficking
Andrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Evolutionary Applications
|
June 28, 2021
Charting a course for genetic diversity in the UN Decade of Ocean Science
Alex Innes Thomson, Frederick I Archer, Melinda A Coleman, et al.
Leukemia & Lymphoma
|
September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL
Niamh Appleby, David O'Brien, Fiona M Quinn, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 97) with videos related to
Sort By:
Page
of 10
ERJ Open Research
|
April 3, 2023
Delivery of noninvasive ventilation to people living with motor neuron disease in the UK
Lucy S Musson, Susan K Baxter, Paul Norman, et al.
Leukemia & Lymphoma
|
April 7, 2010
Large granular lymphocyte leukemia: natural history and response to treatment
Anne F Fortune, Kevin Kelly, Jeremy Sargent, et al.
Cytometry. Part B, Clinical Cytometry
|
September 22, 2018
Inter-laboratory validation of a harmonized PNH flow cytometry assay
Daniel Payne, Ulrika Johansson, David Bloxham, et al.
European Child & Adolescent Psychiatry
|
June 5, 2021
Prioritizing core components of successful transitions from child to adult mental health care: a national Delphi survey with youth, caregivers, and health professionals
Kristin Cleverley, Emma McCann, David O'Brien, et al.
Irish Journal of Medical Science
|
October 17, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias
Helen Fogarty, Anita Dowling, David O'Brien, et al.
BMJ Open
|
February 8, 2017
Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial
Joanna L Henderson, Amy Cheung, Kristin Cleverley, et al.
Brain : a Journal of Neurology
|
June 27, 2025
Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis
David O'Brien, Elham Alhathli, Ceryl Harwood, et al.
Nature Communications
|
April 11, 2020
TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor trafficking
Andrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Evolutionary Applications
|
June 28, 2021
Charting a course for genetic diversity in the UN Decade of Ocean Science
Alex Innes Thomson, Frederick I Archer, Melinda A Coleman, et al.
Leukemia & Lymphoma
|
September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL
Niamh Appleby, David O'Brien, Fiona M Quinn, et al.
Page
of 10